United States Department of Health and Human Services
PulseAugur coverage of United States Department of Health and Human Services — every cluster mentioning United States Department of Health and Human Services across labs, papers, and developer communities, ranked by signal.
- parent of United States Food and Drug Administration 100%
- subsidiary of Federal Government of the United States 100%
- parent of United States National Institutes of Health 100%
- parent of United States Centers for Disease Control and Prevention 100%
- parent of Centers for Medicare and Medicaid Services 100%
- parent of Substance Abuse and Mental Health Services Administration 100%
- parent of Health Resources and Services Administration 100%
- parent of United States Public Health Service 100%
- subsidiary of Centers for Medicare and Medicaid Services 95%
- employed by Robert F. Kennedy Jr. 90%
- subsidiary of United States Food and Drug Administration 90%
- affiliated with Medicaid 90%
14 day(s) with sentiment data
-
Trump's vaccine order faces pushback from doctors and insurers
President Trump has signed an executive order that aims to reduce the number of recommended childhood vaccines from 18 to 11 and suggests splitting the MMR vaccine into three separate administrations. This directive, ho…
-
AI's Essential Role in US Mental Health Care Pledge Highlighted
The U.S. Department of Health and Human Services (HHS) has established a national pledge to improve mental health care, which currently does not mention Artificial Intelligence. The author argues that AI is essential an…
-
Trump signs executive order to revise vaccine schedule, sparking public health concerns
President Trump has signed an executive order to revise the U.S. childhood vaccine schedule, reducing the number of recommended routine vaccinations and proposing that the MMR vaccine be administered as three separate s…
-
ICE to spend millions on LexisNexis data for Palantir deportation platform
U.S. Immigration and Customs Enforcement (ICE) plans to spend millions more on data from LexisNexis to feed into its Palantir platform. This data will support ICE's Enforcement and Removal Operations (ERO) in identifyin…
-
US 340B Drug Program Faces Reforms Amidst Biosimilar Use Debate
The 340B drug pricing program, a significant federal initiative designed to lower medication costs for low-income and uninsured patients, is facing scrutiny and potential reforms. Despite its intent, reports indicate th…
-
FDA faces decision on popular peptides amid safety and efficacy concerns
The FDA is facing a critical decision regarding the authorization of six popular but experimental peptides, which are increasingly being used for health, fitness, and longevity despite limited scientific evidence. Onlin…
-
FDA approves Moderna's mRNA flu vaccine after initial review refusal · 2 sources tracked
The U.S. Food and Drug Administration (FDA) has approved Moderna's mRNA-based flu vaccine, mFlusiva (mRNA-1010), for adults aged 50 and over. This approval follows an initial refusal by the FDA to review the application…
-
Senate Confirms Erica Schwartz as CDC Director Amidst Political Concerns
The U.S. Senate has confirmed Dr. Erica Schwartz as the new director of the Centers for Disease Control and Prevention (CDC) in a 51-44 vote. Schwartz, who has a background in medicine and law, becomes the 22nd leader o…
-
Fauci contempt vote sparks fears of scientist exodus from government
Senate Republicans are pursuing a contempt of Congress vote against Dr. Anthony Fauci, accusing him of refusing to answer questions regarding the COVID-19 pandemic. Critics argue these actions, along with broader effort…
-
Trump administration's health leadership reboot faces vaccine policy challenges
The Trump administration's efforts to reset its health leadership and vaccine policy have encountered significant challenges, with controversial stances on vaccines reportedly resurfacing. Despite attempts to moderate v…
-
Montana advances 'right to try' law for experimental drugs
Montana is advancing a unique plan to become a hub for experimental medical treatments, allowing biotech companies to sell unapproved drugs to consumers. The state has finalized rules for its expanded "right to try" law…
-
Senate panel advances CDC and HHS nominees amid vaccine policy concerns
The Senate health committee has approved the nominations of Erica Schwartz for CDC director and Sean Kaufman for assistant secretary for preparedness and response. Schwartz's nomination passed with a 12-10 vote, while K…
-
Concerns raised over safety of US generic drugs, FDA dismisses claims
A significant portion of generic drugs available in the U.S. are not safe, despite assurances from the FDA. The article criticizes the FDA's dismissal of concerns regarding generic drug quality and safety, particularly …
-
Disease outbreaks reveal global public health system vulnerabilities · 1 source tracked
Recent disease outbreaks, including measles in the United States, cyclosporiasis, and Ebola in Africa, are highlighting significant weaknesses in global public health systems. Declining vaccination rates due to hesitanc…
-
US launches $5B AI-driven Genesis Mission for scientific discovery · 4 sources tracked
The U.S. government has detailed its $5 billion Genesis Mission, a multi-agency initiative aimed at leveraging artificial intelligence to accelerate scientific discovery. Launched via executive order, the mission involv…
-
Trump administration allocates $5bn for AI in science across 15 agencies
The Trump administration has announced a $5 billion initiative to integrate artificial intelligence into scientific research across 15 federal agencies. This plan also involves a significant overhaul of federal research…
-
Trump administration freezes over $1B in Medicaid funds to CA and MN
The Trump administration has halted over $1 billion in Medicaid payments to California and Minnesota due to concerns over questionable claims for in-home care. This action is part of a broader crackdown on fraud within …
-
FDA reviews popular peptides amid safety and efficacy concerns · 2 sources tracked
The U.S. Food and Drug Administration (FDA) is set to review seven peptides for potential approval for compounding by pharmacies. These peptides, including BPC-157, TB-500, and Semax, are popular in longevity and wellne…
-
AI's dual role in healthcare: outbreak detection and cybersecurity threats · 3 sources tracked
Artificial intelligence is being explored for its potential to enhance public health initiatives, including speeding up testing for outbreaks like Cyclospora. Concurrently, AI is also contributing to the rise of sophist…
-
FDA trust plummets amid political interference concerns · 1 source tracked
Public trust in the United States Food and Drug Administration (FDA) has significantly declined, with only about half of Americans now expressing confidence, a drop from roughly three-quarters two years prior. This eros…